SynaxyS

Toulouse, France Founded: 2018 • Age: 8 yrs
5D in-vivo brain models for drug discovery are developed.
Annual revenue - Latest available
Total funding - Funding intelligence
Employees - Tracked headcount
Investors - Known backers
Products 3 Services tracked
Competitors 7 Brand Intelligence

About SynaxyS

SynaxyS is a company based in Toulouse (France) founded in 2018. SynaxyS offers products and services including 5D-Brain Models, Preclinical Assays, and R&D Projects. SynaxyS operates in a competitive market with competitors including bit.bio, Herophilus, Epiloid Biotechnology, Norganoid and Neurxstem, among others.

  • Headquarter Toulouse, France
  • Sectors
    Healthcare
  • Phone
    Locked
  • Website
    Locked
  • Social
    Locked
Operational Areas
Healthcare → Biotechnology, Genomics & Life Sciences Research Unlock Sub-Sector Unlock Segment
Key Metrics
  • Annual Revenue
    Not available
  • Net Profit
    Not available
  • EBITDA
    Not available
  • Latest Funding Round
    Not available
  • Investors
    Not available
  • Employee Count
    Not available
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Products & Services of SynaxyS

SynaxyS offers a comprehensive portfolio of products and services, including 5D-Brain Models, Preclinical Assays, and R&D Projects.

Product name locked
Category locked
Primary

Human models for simulating neuronal activity and testing neurological drugs.

Product name locked
Category locked
Locked

Tests for drug responses on neural functions in controlled environments.

Product name locked
Category locked
Locked

Custom studies for evaluating compound efficacy in neurological disorders.

Funding Insights of SynaxyS

Premium access

Detailed funding history for SynaxyS

Round names, dates, amounts, investors, and valuation history require an active premium plan.

  • Round names and dates
  • Funding amounts
  • Participating investors
  • Valuation history

Verified entity values are shown only after access is granted.

Investments & Acquisitions by SynaxyS

Investments
Premium access

Investment portfolio details for SynaxyS

Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.

  • Portfolio identities
  • Transaction dates
  • Round details
  • Investment values

Verified entity values are shown only after access is granted.

Financial Statements - SynaxyS

Premium access

Detailed financials for SynaxyS

Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.

  • Historical revenue
  • Profit trends
  • Statement rows
  • Financial ratios

Verified entity values are shown only after access is granted.

Synaxys Comparisons

SynaxyS Primary company
Description
5D in-vivo brain models for drug discovery are developed.
Location
Toulouse, France
Founded Year
2018
Annual Revenue
Not available
Net Profit
Not available
EBITDA
Not available
Employees
Not available
Premium access

Peer comparison for SynaxyS

Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.

  • Named peers
  • Headcount comparison
  • Funding comparison
  • Operating benchmarks

Verified entity values are shown only after access is granted.

+
Add Comparison
Available on Premium

Competitors of SynaxyS

SynaxyS operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as bit.bio, Herophilus, Epiloid Biotechnology, Norganoid and Neurxstem, among others.

Company Name Domain Founded year HQ Location Description
Locked Locked Locked
Developer of a platform for synthetic and stem cell therapies
Locked Locked Locked
Developer of drug discovery platform to treat neurological disorders
Locked Locked Locked
3D cerebral organoid assays are provided for neurological drug testing.
Locked Locked Locked
Brain-on-chip solutions are developed to accelerate drug research.
Locked Locked Locked
Neural organoid platform is developed from iPSC for brain research.
Premium access

Detailed competitors of SynaxyS

Competitor domains, locations, full profiles, and operating metrics require an active premium plan.

  • Domains and locations
  • Full company profiles
  • Operating metrics
  • Competitive positioning

Verified entity values are shown only after access is granted.

Latest news on Synaxys

Premium access

Complete news archive for SynaxyS

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about SynaxyS

SynaxyS was founded in 2018.

SynaxyS is headquartered in Toulouse, France. It is registered at Toulouse, Occitanie, France.

Sophie Pautot is the current CEO of SynaxyS.

SynaxyS was founded in 2018 and is headquartered in Toulouse, France. 5D in-vivo brain models are created by the company to facilitate drug discovery in the biotechnology sector. Realistic simulations of brain activity are provided through these models for pharmaceutical applications. Operations are centered on advanced modeling techniques. The role of CEO is held by Sophie Pautot.

SynaxyS's top competitors include bit.bio, Herophilus and Epiloid Biotechnology.

SynaxyS offers 5D-Brain Models, Preclinical Assays, and R&D Projects.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available